Investigating the clinical variables, the number of patients with detectable tumor cells in the prostatic plexus blood was not correlated to Gleason score, TNM-stage, tumor volume, PSA, or BCR-free survival (Table 3). The gene discussed is BCR; the disease is neoplasm.